Repligen Corp at Barclays Global Healthcare Conference Transcript
Thank you and good afternoon. This is Jack Meehan with the Barclays Life Science Tools and Diagnostics team. Pleased to be joined now with Repligen and glad they are joining us in this virtual format with CFO, Jon Snodgres, as well as Head of Investor Relations, Sondra Newman. Thank you, again, and Jon, Sondra, would you like to make any introductory comments?
Yes, we sure would. Thank you, Jack, and pleasure to be here, and thank you guys for continuing the conference virtually.
So quickly, I'll give you an overview of Repligen. For those of you who may not know this -- know us, Repligen is a leading innovator and supplier into the fast-growing bioprocessing market, where we supply products to large biopharmaceutical, CDMO, gene and cell therapy, and other types of customers on a worldwide basis. The overall bioprocessing market that we look at is about $10 billion annually and is expected to grow at an 8%
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |